Those Tested Only Followed For Two Months
Karko noted that the safety data is “very short” – only spanning the period of about two months from inoculation.
“The FDA has a mechanism of approving drugs and vaccines for emergency cases. What this means, is that the FDA has initial safety data. But if this was a usual situation, the researchers would have followed the volunteers for at least two years before the vaccine was approved,” he said.